Short-Term Primary Rifaximin Prophylaxis Has No Beneficial Role in Patients With Cirrhosis.

Autor: Penumarthi SS; Department of Clinical Pharmacy, AIG Hospitals, Hyderabad, India.; Department of Hepatology, AIG Hospitals, Hyderabad, India., Lalkota B; Department of Clinical Pharmacy, AIG Hospitals, Hyderabad, India.; Department of Hepatology, AIG Hospitals, Hyderabad, India., Jangili S; Department of Clinical Pharmacy, AIG Hospitals, Hyderabad, India.; Department of Hepatology, AIG Hospitals, Hyderabad, India., Salla S; Department of Pharmacy, G Pulla Reddy College of Pharmacy, Hyderabad, India., Satti SR; Department of Clinical Pharmacy, AIG Hospitals, Hyderabad, India., Venishetty S; Department of Hepatology, AIG Hospitals, Hyderabad, India., Alla M; Department of Hepatology, AIG Hospitals, Hyderabad, India., Iyengar S; Department of Hepatology, AIG Hospitals, Hyderabad, India., Sharma M; Department of Hepatology, AIG Hospitals, Hyderabad, India., Rao PN; Department of Hepatology, AIG Hospitals, Hyderabad, India., Reddy DN; Department of Hepatology, AIG Hospitals, Hyderabad, India., Kulkarni AV; Department of Hepatology, AIG Hospitals, Hyderabad, India.
Jazyk: angličtina
Zdroj: American journal of therapeutics [Am J Ther] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
DOI: 10.1097/MJT.0000000000001802
Abstrakt: Competing Interests: The authors have no conflicts of interest to declare.
Databáze: MEDLINE